Seven unrelated patients were included: all were female XL-CGD carriers, six with heterozygous pathogenic mutations or deletions in CYBB, and one with a large deletion incorporating CYBB. All patients had clinical features consistent with CGD or with symptomatic XL-CGD carrier status. Here, CYBB is linked to chronic granulomatous disease.